These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33449250)

  • 1. Evaluation of Intranasal Vaccine Delivery Using Anatomical Replicas of Infant Nasal Airways.
    Wilkins JV; Golshahi L; Rahman N; Li L
    Pharm Res; 2021 Jan; 38(1):141-153. PubMed ID: 33449250
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Hosseini S; Wei X; Wilkins JV; Fergusson CP; Mohammadi R; Vorona G; Golshahi L
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):374-385. PubMed ID: 31464547
    [No Abstract]   [Full Text] [Related]  

  • 3. In Vitro Comparison of Local Nasal Vaccine Delivery and Correlation with Device Spray Performance.
    Li L; Wilkins JV; Esmaeili AR; Rahman N; Golshahi L
    Pharm Res; 2023 Feb; 40(2):537-550. PubMed ID: 36536098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro assessment of an idealized nose for nasal spray testing: Comparison with regional deposition in realistic nasal replicas.
    Chen JZ; Kiaee M; Martin AR; Finlay WH
    Int J Pharm; 2020 May; 582():119341. PubMed ID: 32305365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing regional drug delivery within the nasal airways.
    Chen J; Finlay WH; Vehring R; Martin AR
    Expert Opin Drug Deliv; 2024 Apr; 21(4):537-551. PubMed ID: 38568159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal vaccines.
    Davis SS
    Adv Drug Deliv Rev; 2001 Sep; 51(1-3):21-42. PubMed ID: 11516777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro evaluation of importance of airway anatomy in sub-regional nasal and paranasal drug delivery with nebulizers using three different anatomical nasal airway replicas of 2-, 5- and 50-Year old human subjects.
    Hosseini S; Golshahi L
    Int J Pharm; 2019 May; 563():426-436. PubMed ID: 30974192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Filtration of Inhaled Aerosol in Human Subjects as a Function of Nasal Pressure Drop.
    Golshahi L; Hosseini S
    J Aerosol Med Pulm Drug Deliv; 2019 Feb; 32(1):13-23. PubMed ID: 30199315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations to Estimate the Key Anatomical Dimensions of Pediatric Nasal Airways using Minimally Invasive Measurements of Intranasal Pressure Gradient.
    Hosseini S; Schuman TA; Golshahi L
    J Aerosol Med Pulm Drug Deliv; 2021 Jun; 34(3):171-180. PubMed ID: 32833574
    [No Abstract]   [Full Text] [Related]  

  • 10. Dry powder nasal vaccines as an alternative to needle-based delivery.
    Hickey AJ; Garmise RJ
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):1-27. PubMed ID: 19496746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of nasal and laryngeal airways in children: implications in breathing and inhaled aerosol dynamics.
    Xi J; Si X; Zhou Y; Kim J; Berlinski A
    Respir Care; 2014 Feb; 59(2):263-73. PubMed ID: 23821760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized Medicine in Nasal Delivery: The Use of Patient-Specific Administration Parameters To Improve Nasal Drug Targeting Using 3D-Printed Nasal Replica Casts.
    Warnken ZN; Smyth HDC; Davis DA; Weitman S; Kuhn JG; Williams RO
    Mol Pharm; 2018 Apr; 15(4):1392-1402. PubMed ID: 29485888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M-052 liposomes): In vitro characterization.
    Murphy BM; Chen JZ; Rolo M; Eldam M; Jordan L; Sivananthan SJ; Kinsey R; Guderian JA; Pedersen K; Abhyankar M; Petri WA; Fox CB; Finlay WH; Vehring R; Martin AR
    Int J Pharm; 2022 Oct; 626():122141. PubMed ID: 36058408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A; Sánchez A; Janes K; Behrens I; Kissel T; Vila Jato JL; Alonso MJ
    Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-based delivery systems for mucosal vaccines.
    Jabbal-Gill I; Watts P; Smith A
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1051-67. PubMed ID: 22708875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal formulations: promising strategy to deliver vaccines.
    Riese P; Sakthivel P; Trittel S; Guzmán CA
    Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal route for vaccine and drug delivery: Features and current opportunities.
    Lobaina Mato Y
    Int J Pharm; 2019 Dec; 572():118813. PubMed ID: 31678521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal nanovaccines.
    Bernocchi B; Carpentier R; Betbeder D
    Int J Pharm; 2017 Sep; 530(1-2):128-138. PubMed ID: 28698066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques: In Vitro Tests and Numerical Simulations.
    Xi J; Wang Z; Nevorski D; White T; Zhou Y
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):118-131. PubMed ID: 27977306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.